ABOUT US
A global leader in innovative genomic
technology and diagnostic tests.
Highly recognized in the field of genomics.
Our team comprises scientists, clinicians, innovators and survivors, all dedicated to delivering breakthroughs that improve the outcomes and quality of life for patients with breast cancer. With decades of expertise Agendia is at the forefront of healthcare innovation.
Executive Management
Our founders are recognized leaders in the field of genomics. Their prominent roles at comprehensive cancer centers put Agendia in an excellent position to partner with the academic world.
Mark R. Straley
Chief Executive Officer
Kurt Becker
Chief Operating Officer
Brian Dow
Chief Financial Officer
William Audeh, MD, MS
Chief Medical Officer
Roopom Banerjee
Chief Strategy Officer & Head of Business Development
Franklin Libenson, MD, MPH
Interim, Chief Commercial Officer
Bastiaan Van Der Baan
Chief Clinical & Business Development Officer
Prof. Laura van ‘t Veer, PhD
Chief Research Officer, Co-founder
Prof. Dr. René Bernards, PhD
Chief Scientific Officer, Co-founder
Christy Garcia
Vice President, Compliance
Board of Directors
Patrick J. Balthrop
Supervisory Board Chairman
An Van Es
Supervisory Board Member
Erik Esveld
Supervisory Board Member
Françoise Ferré
Supervisory Board Member
Laurie Heilmann
Supervisory Board Member
Peter Stein
Supervisory Board Member
Christoph Waer
Supervisory Board Member
